Lumiphore develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. These include biological detection systems based on luminescent lanthanide complexes (which provide a unique combination of sensitivity, reliability, flexibility and high throughput) and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics.

Excitation induced long-lived green luminescence exhibited by one of Lumiphore’s terbium complexes.

Read more about this »

A 3-dimensional representation of the complex which gives rise to the green luminescence.

Read more about this »

Lumiphore Technology Presented at the American Association for Cancer Research Annual Meeting
Biophor Diagnostics, Inc. Announces Seventh FDA 510(k) Clearance
Algeta and Lumiphore Announce Further Expansion of their Global Partnership for the Development of Targeted Alpha-Pharmaceutical Cancer Therapeutics and Companion Diagnostics.
Lumiphore Announce Brahms diagnostic launch in Europe
Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-pharmaceutical Therapeutics